Related Experiment Video
Updated: Jun 13, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Vitamin D receptor gene polymorphism and bone mineral density in 0-6-year-old Han children
Xiao-Dan Yu1, Xiao-Ming Shen, Ming-Bao Xue
1Shanghai Institute of Pediatric Research, Xinhua Hospital, Medical School of Shanghai Jiaotong University, Shanghai, China.
Insights
Certain vitamin D receptor (VDR) gene variants, specifically BsmI (Bb) and FokI (ff), are linked to lower bone mineral density (BMD) in young Chinese children. Other VDR gene variants showed no significant association with BMD in this pediatric cohort.
Area of Science:
- Genetics
- Pediatrics
- Bone Metabolism
Background:
- Bone mineral density (BMD) is crucial for skeletal health in children.
- Genetic factors, including vitamin D receptor (VDR) gene polymorphisms, may influence BMD.
- Understanding these genetic associations is important for early identification of children at risk for bone health issues.
Purpose of the Study:
- To investigate the association between four single nucleotide polymorphisms (SNPs) in the VDR gene and BMD in Chinese children aged 0-6 years.
- To determine if VDR gene variants (ApaI, BsmI, TaqI, FokI) are related to BMD in this pediatric population.
- To identify specific VDR genotypes associated with altered bone mineral density in early childhood.
Main Methods:
- Recruited 204 Han Chinese children aged 0-6 years without metabolic bone disease.
- Measured bone mineral density (BMD) of the middle tibia using an ultrasonic bone density instrument.
- Determined VDR genotypes (ApaI, BsmI, TaqI, FokI) using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP).
Main Results:
- The VDR BsmI (Bb genotype) and FokI (ff genotype) variants were significantly associated with decreased BMD.
- Children with the VDR BsmI Bb genotype had significantly lower BMD compared to bb carriers (P < 0.05).
- Children with the VDR FokI ff genotype exhibited significantly lower BMD than Ff or FF carriers (P < 0.001).
- VDR ApaI and TaqI polymorphisms showed no significant association with BMD in this cohort.
- Predominant alleles were a, T, b, and F, with frequencies of 70.6%, 95.8%, 95.3%, and 57.6%, respectively.
Conclusions:
- The VDR BsmI (Bb) and FokI (ff) genotypes are significantly associated with reduced bone mineral density in young Chinese Han children.
- VDR ApaI and TaqI polymorphisms do not appear to influence BMD in this specific pediatric group.
- These findings highlight the role of specific VDR gene variants in early childhood bone health and may inform targeted interventions.
Abstract:
This study aims to investigate the four vitamin D receptor (VDR) gene single nucleotide polymorphisms and their possible relationship with bone mineral density (BMD) in Chinese 0-6-year-old Han children. Two hundred four 0-6-year-old Han children without metabolic bone disease were randomly recruited in Shanghai, China. The BMD of the middle tibia was measured by an ultrasonic bone density instrument. VDR genotypes were determined by polymerase chain reaction restriction fragment length polymorphism using endonuclease ApaI, BsmI, TaqI and FokI. The alleles of a, T, b and F and the genotypes of aa, TT, bb and Ff were predominant. The frequency alleles of a, T, b and F were, respectively, 70.6, 95.8, 95.3 and 57.6%. When the influences of confounders such as serum 25(OH)D, serum zinc and outdoor activities on BMD were removed, the genotypes of BsmI and FokI were found apparently to be related to BMD. The BMD of the Bb carrier was much lower than that of the bb carrier (22.00 ± 27.84 and 43.14 ± 31.98, P < 0.05). The BMD of the ff carrier was lower than that of the Ff or FF carrier (26.97 ± 34.22 and 37.95 ± 29.70 and 53.52 ± 30.35, P < 0.001), while the genotypes of ApaI and TaqI have no relation with BMD in 0-6-year-old Han children. These findings show that the Bb and ff genotypes of the VDR BsmI and FokI variants are significantly associated with a decreased BMD in Chinese Han children aged 0-6 years, while the VDR ApaI and TaqI polymorphisms are not significantly associated with it.
Related Concept Videos
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu